/ARGX

argenx SE

ARGX

$1,011.11USD↓-2.76%-28.67 today

MARKET CAP

47.0B

P/E (TTM)

32.7x

FWD P/E

27.1x

DAY RANGE

$1,002 – $1,031

52W RANGE

$659

$1,059

AI Summary

Stalk

StalkMedium

ARGX has delivered a high-conviction momentum breakout in a Stage 2 advance, reinforcing a bullish medium-term bias. However, short-term conditions are extremely overbought and extended, warranting patience. Execution is best deferred to pullbacks into the rising 9-day and 20-day EMAs near the recent breakout support for structurally favorable entries.

↑Q2’26 VivGuard net sales $1.5B, +60% YoY adoption in MG/CIDP
↑PDUFA May 10, 2026 for seronegative MG could expand addressable market by ~11K patients
↓Q2’26 operating expenses hit $1B, pressuring profit margins

Full analysis →

Buying

8

institutions

Selling

5

institutions

New Positions

2

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	5.08 M	3.70 B	+2.63 M	+79.6%	0.90%
BI Blackrock, Inc. Q2 2026	SELL	777.24 K	721.10 M	+-31.10 K	+22.2%	0.01%
CA Citadel Advisors LLC Q2 2026	SELL	273.32 K	253.57 M	+-16.91 K	+19.6%	0.03%
MM Millennium Management LLC Q2 2026	BUY	94.40 K	87.58 M	+22.04 K	+65.7%	0.03%
WP Woodline Partners LP Q2 2026	BUYNEW	55.02 K	51.05 M	+55.02 K	+0.0%	0.16%
PA Point72 Asset Management, L.P. Q2 2026	BUY	45.78 K	42.48 M	+38.68 K	+719.3%	0.05%
VI Voloridge Investment Management, LLC Q2 2026	SELL	18.80 K	17.44 M	+-3.85 K	+5.4%	0.07%
JC Jpmorgan Chase & Co Q2 2026	BUY	15.63 K	14.26 M	+2.62 K	+55.7%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	10.67 K	9.90 M	+8.14 K	+435.8%	0.00%
BA Bridgewater Associates, LP Q2 2026	BUY	1.96 K	1.82 M	+744.00	+104.9%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	828.00	768.45 K	+-108.00	+12.4%	0.00%
FA Fisher Asset Management, LLC Q2 2026	BUYNEW	318.00	295.91 K	+318.00	+0.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-13.11 K	-100.0%	0.00%